Cargando…

Opicapone for Parkinson’s disease

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Therapeutic Guidelines 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664095/
http://dx.doi.org/10.18773/austprescr.2023.012
_version_ 1785148698966097920
collection PubMed
description
format Online
Article
Text
id pubmed-10664095
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Therapeutic Guidelines
record_format MEDLINE/PubMed
spelling pubmed-106640952023-12-05 Opicapone for Parkinson’s disease Aust Prescr New Drug Therapeutic Guidelines 2023-08-22 2023-08 /pmc/articles/PMC10664095/ http://dx.doi.org/10.18773/austprescr.2023.012 Text en (c) Therapeutic Guidelines https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drug
Opicapone for Parkinson’s disease
title Opicapone for Parkinson’s disease
title_full Opicapone for Parkinson’s disease
title_fullStr Opicapone for Parkinson’s disease
title_full_unstemmed Opicapone for Parkinson’s disease
title_short Opicapone for Parkinson’s disease
title_sort opicapone for parkinson’s disease
topic New Drug
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664095/
http://dx.doi.org/10.18773/austprescr.2023.012